| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/28/2004 | CN1516600A Combinatino medicament for treatment of neoplastic diseases |
| 07/28/2004 | CN1516592A Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancers, diabetes, premenstrual syndrome and transdermal transport |
| 07/28/2004 | CN1516587A Quinazoline derivatives capable of promoting release of parathyroid |
| 07/28/2004 | CN1516580A Sulfonamides |
| 07/28/2004 | CN1516578A Process for preparation of dispersions |
| 07/28/2004 | CN1515567A New benzothiaheptylyin with ileal bile acid transfer and taurocholate absorption inhibitor activity |
| 07/28/2004 | CN1515562A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/28/2004 | CN1515559A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/28/2004 | CN1515548A Oxaminic acid used as thyroid gland receptor ligand and its derivative |
| 07/28/2004 | CN1515534A Non-cyclic 1,3-dicarbonyl PPAR double-activation compound with sugar-reducing lipid-reducing activity and preparation method of its medicinal preparation |
| 07/28/2004 | CN1515317A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515316A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515313A Guibiegongjiang capsule and its preparation method |
| 07/28/2004 | CN1515311A Blood-lipid-reducing thrombolytic medicine |
| 07/28/2004 | CN1515293A Natural medicine for reducing blood fat and its production method |
| 07/28/2004 | CN1515280A Maikary oral liquor |
| 07/28/2004 | CN1515259A 4-aminosubstituted-2-substituted-1,2,3,4-tetrahydroquinoline used as CETP inhibitor |
| 07/28/2004 | CN1515258A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515257A Paroxetine control-released composite |
| 07/28/2004 | CN1515256A Application of estrogen antagonist and estrogen excitent for inhibiting pathological disease |
| 07/28/2004 | CN1515254A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515252A Application of indole derivative as SHTI excitomotor |
| 07/28/2004 | CN1515249A Amino acid nutrient enriching agent and its preparation method |
| 07/28/2004 | CN1515247A Paint film based on dextrin and its composite |
| 07/28/2004 | CN1159422C Preparation of additive for food, medicine anfd cosmetics and teplenishing linolic acid and gamma-linolenic acid |
| 07/28/2004 | CN1159341C Method of treatment of corticosteroid induced osteopenia |
| 07/28/2004 | CN1159316C Iso-Indolo-indolone compound, their preparation methods and drug compositions comprising the same |
| 07/28/2004 | CN1159314C Thiazolidinedione derivs. as antidiabetic agents |
| 07/28/2004 | CN1159313C Alkali-metal or alkali-earth metal salt of polyprotic acid delotadine and its medical composition |
| 07/28/2004 | CN1159306C Substituted 8,8a-dihydro-3aH-indeno[1,2-D] thiazoles, a method for their production and their use as medicaments |
| 07/28/2004 | CN1159305C Novel 2-(N-cyanoimino) thiazolidin-4-one derivatives |
| 07/28/2004 | CN1159281C Composition containing conjugated calcium linoleate and making method thereof |
| 07/28/2004 | CN1159051C Shiweijiangtang pill for reducing blood sugar and its prepn |
| 07/28/2004 | CN1159050C Composite chinese medicine preparation for treating type II diabetes |
| 07/28/2004 | CN1159047C Composition with weight-losing and blood-fat reducing actions |
| 07/28/2004 | CN1159044C Process for preparing fat-reducing table |
| 07/28/2004 | CN1159029C Blood lipoid regulating medicine and its prepn |
| 07/28/2004 | CN1159022C Ginkgo leaves composition and preparation method and uses |
| 07/28/2004 | CN1159019C Extractable compounds and method for making and using the same |
| 07/28/2004 | CN1159009C Pharmaceutical use of benzoci acid derivatives |
| 07/28/2004 | CN1159003C Locally-used weight reducing face-care compsns. |
| 07/28/2004 | CN1159000C Buccal delivery system |
| 07/28/2004 | CN1158999C Controlled release oral tablet having a unitary core |
| 07/27/2004 | US6767917 Diuretics; cardiovascular, kidney and brain disorder treatment; antitumor, antiallergen, and antiasthmatic agents |
| 07/27/2004 | US6767915 Substituted piperidines as melanocortin receptor agonists |
| 07/27/2004 | US6767909 Cardiovascular disorders; vasoconstriction |
| 07/27/2004 | US6767894 Use of ciliary neurotrophic factor |
| 07/27/2004 | US6767887 Peptides that stimulate release of insulin; treating diabetes |
| 07/27/2004 | US6767736 Human ion channel protein and polynucleotides encoding the same |
| 07/27/2004 | US6767565 Recovering lignans from plants; obtain plant biomass, expose to extraction solvent, separate solid plant material, remove microorganism from extraction solution, recover lignan |
| 07/27/2004 | US6767020 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle |
| 07/27/2004 | CA2129261C Processes of producing amylase inhibitors |
| 07/24/2004 | WO2003059904A1 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 07/22/2004 | WO2004061073A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/22/2004 | WO2004060888A1 Novel cb 1 receptor inverse agonists |
| 07/22/2004 | WO2004060875A1 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 07/22/2004 | WO2004060871A1 Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds |
| 07/22/2004 | WO2004060870A1 Novel cb 1 receptour inverse agonists |
| 07/22/2004 | WO2004060487A2 Composition for the treatment of hiv or aids |
| 07/22/2004 | WO2004060401A1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 07/22/2004 | WO2004060399A1 Body weight gain inhibitor |
| 07/22/2004 | WO2004060369A1 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes |
| 07/22/2004 | WO2004060368A1 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of islets of langerhans cells |
| 07/22/2004 | WO2004050115A3 Combination treatment using exendin-4 and thiazolidinediones |
| 07/22/2004 | WO2004039978A3 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 07/22/2004 | WO2004037861A3 Neutralizing antibodies against gdf-8 and uses therefor |
| 07/22/2004 | WO2004028554A3 Skrp, astray, string, vacm associated with metabolic control |
| 07/22/2004 | WO2004006835A3 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 07/22/2004 | WO2003087086A3 Substituted indoles |
| 07/22/2004 | WO2003074560A3 Critical hypoxia-inducible factor-1alpha residues, products and methods related thereto |
| 07/22/2004 | WO2003072135A3 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 07/22/2004 | WO2003059293A3 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 07/22/2004 | WO2003006002A9 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 07/22/2004 | WO2002088090A3 Pyrazole derived kinase inhibitors |
| 07/22/2004 | US20040143136 hydrolysis of 4,4-dimethyl-2-oxetanone with aqueous sodium hydroxide; absorbion onto synthetic silicic acid; lightly hygroscopic and easily handled. |
| 07/22/2004 | US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required |
| 07/22/2004 | US20040143095 for treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety; angiogenesis inhibitors; genetic engineering |
| 07/22/2004 | US20040143015 Mixture of antidiabetic agents and carrier; prevent, delay metabolism disorders |
| 07/22/2004 | US20040143006 Peroxisome proliferator activator; antidiabetic agents; insulin resistance; |
| 07/22/2004 | US20040143003 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142976 Modulation cytokine sensitive diseases, cellular adhesion molecules; Aids therapy; antihistamines; antiarthritic agents; bone disorders; malaria; cachexia; Crohn's disease |
| 07/22/2004 | US20040142961 Utilization of substituted imidazo[1,2-a]-pyridine compounds in pharmaceutical formulations |
| 07/22/2004 | US20040142935 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor liqands and/or serotonergic ligands |
| 07/22/2004 | US20040142934 treatment of rheumatoid arthritis and/or pain; INHIBIT activity of VEGF receptor tyrosine kinase and VEGF-dependent cell proliferation |
| 07/22/2004 | US20040142927 Inhibitors of p38 |
| 07/22/2004 | US20040142923 inhibitors of urotensin II |
| 07/22/2004 | US20040142921 treatment and/or prevention of type 2 diabetes and associated metabolic syndrome |
| 07/22/2004 | US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases |
| 07/22/2004 | US20040142912 Treatment of systemic lupus erythematosis |
| 07/22/2004 | US20040142901 Production of pancreatic islet cells and delivery of insulin |
| 07/22/2004 | US20040142879 Use of the acetyl l-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus |
| 07/22/2004 | US20040142877 Ligands of the $g(a)v$g(b)6 integrin |
| 07/22/2004 | US20040142866 Derivatives of the insulinotropic peptide exendin-4 and methods of production thereof |
| 07/22/2004 | US20040142432 Preparing single chain antibodies comprised of camelid subunits for treating and preventing inflammation, allergies, cancer, infections, transplant rejection, autoimmune and muscular disorders |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142391 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with RAGE |
| 07/22/2004 | US20040142382 Immunoglobulin against growth differentiation factor -8 (GDF-8) for use in the prevention and treatment of bone, muscular, nervous system and obesity; muscle enhancement |
| 07/22/2004 | US20040142047 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof |
| 07/22/2004 | US20040142018 Regulator for amount of body fat |